Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Morgan

Showing results (601-610 of 1,740) with videos related to

Pageof 174
Sort By:
Veterinary Surgery : VS|May 1, 1988
Cervical chemonucleolysis in the dog. A surgical techniqueM A Atilola, C S Bailey, J P Morgan
British Journal of Hospital Medicine (London, England : 2005)|May 30, 2006
Percutaneous coronary intervention for revascularization of the diabetic patientJeremy N Butts, Kenneth P Morgan, Kevin J Beatt
International Journal of Sports Medicine|August 1, 1997
Influence of acute physical activity and relaxation on state anxiety and blood lactate in untrained college malesA W Garvin, K F Koltyn, W P Morgan
Basic Research in Cardiology|January 1, 1992
Pathophysiology of cardiac hypertrophy and failure of human working myocardium: abnormalities in calcium handlingA J Meuse, C L Perreault, J P Morgan
Neuroscience and Biobehavioral Reviews|May 1, 2019
How the motor system integrates with working memoryCherie L Marvel, Owen P Morgan, Sharif I Kronemer
Immunology|August 14, 1999
Tissue distribution of the rat analogue of decay-accelerating factorO B Spiller, S M Hanna, B P Morgan
The Biochemical Journal|July 27, 1999
Molecular and functional analysis of mouse decay accelerating factor (CD55)C L Harris, N K Rushmere, B P Morgan
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 22, 2001
Intravascular ultrasound diagnosis of cystic adventitial degeneration of the popliteal artery: a case reportM T Foster, J T Collins, J P Morgan
The Veterinary Record|April 17, 2012
Successful medical treatment of Erysipelothrix rhusiopathiae-induced lumbosacral diskospondylitis in a dogL Golini, J P Morgan, T Glaus, et al.
Immunology|August 6, 2000
Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activitiesC L Harris, O B Spiller, B P Morgan
Pageof 174

Showing results (601-610 of 1,740) with videos related to

Sort By:
Pageof 174
Veterinary Surgery : VS|May 1, 1988
Cervical chemonucleolysis in the dog. A surgical techniqueM A Atilola, C S Bailey, J P Morgan
British Journal of Hospital Medicine (London, England : 2005)|May 30, 2006
Percutaneous coronary intervention for revascularization of the diabetic patientJeremy N Butts, Kenneth P Morgan, Kevin J Beatt
International Journal of Sports Medicine|August 1, 1997
Influence of acute physical activity and relaxation on state anxiety and blood lactate in untrained college malesA W Garvin, K F Koltyn, W P Morgan
Basic Research in Cardiology|January 1, 1992
Pathophysiology of cardiac hypertrophy and failure of human working myocardium: abnormalities in calcium handlingA J Meuse, C L Perreault, J P Morgan
Neuroscience and Biobehavioral Reviews|May 1, 2019
How the motor system integrates with working memoryCherie L Marvel, Owen P Morgan, Sharif I Kronemer
Immunology|August 14, 1999
Tissue distribution of the rat analogue of decay-accelerating factorO B Spiller, S M Hanna, B P Morgan
The Biochemical Journal|July 27, 1999
Molecular and functional analysis of mouse decay accelerating factor (CD55)C L Harris, N K Rushmere, B P Morgan
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 22, 2001
Intravascular ultrasound diagnosis of cystic adventitial degeneration of the popliteal artery: a case reportM T Foster, J T Collins, J P Morgan
The Veterinary Record|April 17, 2012
Successful medical treatment of Erysipelothrix rhusiopathiae-induced lumbosacral diskospondylitis in a dogL Golini, J P Morgan, T Glaus, et al.
Immunology|August 6, 2000
Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activitiesC L Harris, O B Spiller, B P Morgan
Pageof 174